Dr. Tiffany Lin has over 15 years of drug development experience and joined Certara as a Clinical Pharmacologist in 2016. She is experienced in clinical drug development with a focus in oncology. Dr. Lin is currently leading project teams with a focus on Clinical Pharmacology Study Execution.
Prior to joining Certara, Dr. Lin was a Clinical Pharmacologist in industry where she provided strategic and quantitative support for the development of two small molecule oncology drugs that were approved for multiple indications in the US, EU and APAC regions. She obtained her PharmD at the Massachusetts College of Pharmacy and completed a post-doctoral fellowship at Hofmann La-Roche and the FDA, through the Rutgers University Program.